Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
| ▸ | IGF1R | P08069 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.34 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | TYK2 | P29597 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953210 | 0.93 | AAK1 (0.46) | AAK1IGF1RMMP1NR3C2ATM | |
| SCHEMBL30953293 | 0.88 | AAK1 (0.41) | AAK1CDK5DYRK1ACDK5R1IGF1R | |
| SCHEMBL30953221 | 0.88 | AAK1 (0.48) | AAK1CDK5DYRK1ACDK5R1IGF1R | |
| SCHEMBL27393615 | 0.88 | AAK1 (0.48) | AAK1CDK5DYRK1ACDK5R1IGF1R | |
| SCHEMBL30953319 | 0.87 | AAK1 (0.55) | AAK1CDK5DYRK1ACDK5R1MMP1 | |
| SCHEMBL30952941 | 0.86 | AAK1 (0.39) | AAK1CDK5DYRK1ACDK5R1IGF1R | |
| SCHEMBL30953311 | 0.85 | AAK1 (0.44) | AAK1MMP1IDO1MAPK1 | |
| SCHEMBL30953417 | 0.85 | AAK1 (0.44) | AAK1 | |
| SCHEMBL30953223 | 0.85 | AAK1 (0.44) | AAK1KMT2AMEN1MAPK1 | |
| SCHEMBL30953388 | 0.85 | AAK1 (0.46) | AAK1IGF1RMMP1IDO1TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |